Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

289 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Surgery versus radiation for clinically positive nodal prostate cancer in an other cause mortality risk weighted cohort.
Tinsley SA, Stephens A, Finati M, Chiarelli G, Cirulli GO, Morrison C, Richard C, Hares K, Lutchka J, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: carrieri g. Int Urol Nephrol. 2024 Nov 11. doi: 10.1007/s11255-024-04253-9. Online ahead of print. Int Urol Nephrol. 2024. PMID: 39528898
Adequacy of prostate cancer prevention and screening recommendations provided by an artificial intelligence-powered large language model.
Chiarelli G, Stephens A, Finati M, Cirulli GO, Beatrici E, Filipas DK, Arora S, Tinsley S, Bhandari M, Carrieri G, Trinh QD, Briganti A, Montorsi F, Lughezzani G, Buffi N, Rogers C, Abdollah F. Chiarelli G, et al. Among authors: carrieri g. Int Urol Nephrol. 2024 Aug;56(8):2589-2595. doi: 10.1007/s11255-024-04009-5. Epub 2024 Apr 2. Int Urol Nephrol. 2024. PMID: 38564079
Race has no impact on prostate cancer-specific mortality, when comparing patients with similar risk of other-cause mortality: An analysis of a population-based cohort.
Tinsley SA, Finati M, Stephens A, Chiarelli G, Cirulli GO, Williams E, Morrison C, Richard C, Hares K, Sood A, Buffi N, Lughezzani G, Bettocchi C, Salonia A, Briganti A, Montorsi F, Carrieri G, Rogers C, Abdollah F. Tinsley SA, et al. Among authors: carrieri g. Cancer. 2024 Sep 15;130(18):3157-3169. doi: 10.1002/cncr.35386. Epub 2024 May 28. Cancer. 2024. PMID: 38804713
The Role of Baseline Prostate-specific Antigen Value Prior to Age 60 in Predicting Lethal Prostate Cancer: Analysis of a Contemporary North American Cohort.
Finati M, Davis M, Stephens A, Chiarelli G, Cirulli GO, Morrison C, Affas R, Sood A, Buffi N, Lughezzani G, Briganti A, Montorsi F, Carrieri G, Rogers C, Vickers AJ, Abdollah F. Finati M, et al. Among authors: carrieri g. Eur Urol Oncol. 2024 Jul 10:S2588-9311(24)00172-X. doi: 10.1016/j.euo.2024.06.014. Online ahead of print. Eur Urol Oncol. 2024. PMID: 38991891
Impact of Prostate-Specific Antigen Screening Pattern on Prostate Cancer Mortality Among Non-Hispanic Black and Non-Hispanic White Men: A Large, Urban Health System Cohort Analysis.
Cirulli GO, Davis M, Stephens A, Chiarelli G, Finati M, Corsi N, Williams E, Affas R, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Cirulli GO, et al. Among authors: carrieri g. J Urol. 2024 Oct;212(4):560-570. doi: 10.1097/JU.0000000000004118. Epub 2024 Jul 30. J Urol. 2024. PMID: 39079152
Radical cystectomy versus trimodal therapy for muscle-invasive bladder cancer: Analysis of an other-cause mortality matched cohort.
Finati M, Stephens A, Chiarelli G, Cirulli GO, Tinsley S, Wang Y, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Carrieri G, Rogers C, Abdollah F. Finati M, et al. Among authors: carrieri g. Urol Oncol. 2024 Sep 5:S1078-1439(24)00572-6. doi: 10.1016/j.urolonc.2024.08.001. Online ahead of print. Urol Oncol. 2024. PMID: 39242301
The Impact of Radical Prostatectomy Versus Radiation Therapy on Cancer-Specific Mortality for Nonmetastatic Prostate Cancer: Analysis of an Other-Cause Mortality Matched Cohort.
Finati M, Corsi NJ, Stephens A, Chiarelli G, Cirulli GO, Davis M, Tinsley S, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Bettocchi C, Carrieri G, Rogers C, Abdollah F. Finati M, et al. Among authors: carrieri g. Clin Genitourin Cancer. 2024 Aug 13;22(6):102201. doi: 10.1016/j.clgc.2024.102201. Online ahead of print. Clin Genitourin Cancer. 2024. PMID: 39243664
Association of race with incidence, characteristics, and mortality from incidental prostate cancer: Analysis of two North American contemporary cohorts.
Finati M, Morrison C, Stephens A, Chiarelli G, Cirulli GO, Tinsley S, Davis M, Sood A, Buffi N, Lughezzani G, Salonia A, Briganti A, Montorsi F, Busetto GM, Bettocchi C, Rogers C, Carrieri G, Abdollah F. Finati M, et al. Among authors: carrieri g. Prostate. 2024 Oct 28:e24803. doi: 10.1002/pros.24803. Online ahead of print. Prostate. 2024. PMID: 39465565
Impact of lymphovascular invasion on survival in surgically treated upper tract urothelial carcinoma: a nationwide analysis.
Cirulli GO, Corsi N, Rakic I, Stephens A, Chiarelli G, Finati M, Davis M, Tinsley S, Sood A, Buffi N, Lughezzani G, Carrieri G, Salonia A, Briganti A, Montorsi F, Rogers C, Abdollah F. Cirulli GO, et al. Among authors: carrieri g. BJU Int. 2024 May;133(5):555-563. doi: 10.1111/bju.16258. Epub 2024 Jan 8. BJU Int. 2024. PMID: 38097533
289 results